CNS effects of convulsive therapy: significance for a theory of depressive psychosis.
D000513:Alpha Rhythm; D000654:Amobarbital / Q000494:pharmacology; D000928:Antidepressive Agents / Q000494:pharmacology; D001714:Bipolar Disorder / Q000628:therapy; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D003863:Depression / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D004565:Electroconvulsive Therapy; D004566:Electrodes; D004569:Electroencephalography; D004594:Electrophysiology; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D009482:Neurophysiology; D010433:Pentylenetetrazole / Q000494:pharmacology; D011352:Procyclidine / Q000494:pharmacology; D011618:Psychotic Disorders / Q000209:etiology / Q000628:therapy*; D012640:Seizures / Q000139:chemically induced
D000928:Antidepressive Agents; D008238:Lysergic Acid Diethylamide; D008094:Lithium; D011352:Procyclidine; D000654:Amobarbital; D010433:Pentylenetetrazole